Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.69 +1.48 (+3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Non Operating Investment Income (2023 - 2025)

Updated

Bright Minds Biosciences (DRUG) posted Non Operating Investment Income of -$5.42 million for fiscal Q1 2026 (quarter ended Dec 31, 2025), compared with $35,513 a year earlier.

Analysis

Bright Minds Biosciences (DRUG) Non Operating Investment Income (2023 - 2025) Analysis & Trends

For the trailing twelve months through Dec 31, 2025, Non Operating Investment Income at Bright Minds Biosciences was -$6.46 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Bright Minds Biosciences 387.06 Mn 387.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -5.42 Mn
Dec 31, 2024 35,513.28
Jun 30, 2024 168,091.41
Dec 31, 2023 -1.24 Mn
Jun 30, 2023 -1.09 Mn
API Access

Bright Minds Biosciences Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=DRUG&period=max&api_key=YOUR_API_KEY